More Information on Novel Coronavirus Infection

24 January 2020 -  Novel Coronavirus Update

The number of confirmed cases of novel coronavirus (2019-nCoV) infection has increased to around 844
with 25 deaths. Most cases continue to be reported from Wuhan, China, but cases have now been reported
from 25 provinces in China. Additionally a small numbers of cases, all with links to Wuhan, have been
reported in South Korea, Japan, Thailand, USA, Hong Kong, Taiwan and Macau. The age range of
confirmed cases is 15-89 years. To date there are no confirmed cases in Australia.

Fever has been the single consistent symptom, with other symptoms including cough (dry or productive),
fatigue, chest discomfort, sore throat, difficulty breathing, headache and chest radiographs showing
bilateral pneumonic infiltrations. The incubation period thought to be 4-14 days with an average of 7 days.

COMMUNICABLE DISEASE 
CONTROL BRANCH
- Attention all doctors - 
Date:24/01/2020 Contact telephone number: 1300 232 272  (24 hours/7 days)

 

More Information on Novel Coronavirus Infection

 

The number of confirmed cases of novel coronavirus (2019-nCoV) infection has increased to around 844 
with 25 deaths. Most cases continue to be reported from Wuhan, China, but cases have now been reported 
from 25 provinces in China. Additionally a small numbers of cases, all with links to Wuhan, have been 
reported in South Korea, Japan, Thailand, USA, Hong Kong, Taiwan and Macau. The age range of 
confirmed cases is 15-89 years. To date there are no confirmed cases in Australia.

Fever has been the single consistent symptom, with other symptoms including cough (dry or productive), 
fatigue, chest discomfort, sore throat, difficulty breathing, headache and chest radiographs showing 
bilateral pneumonic infiltrations. The incubation period thought to be 4-14 days with an average of 7 days

Suspected cases require BOTH epidemiological AND clinical criteria
Epidemiological criteria: at least one of the following

  • Travel to Wuhan City (Hubei Province, China) in the 14 days before the onset of illness.
  • Travel to an area with evidence of sustained human-to-human transmission, or a declared outbreak,
    within 14 days before onset of illness.
  • Close contact in the 14 days before illness onset with a case of 2019-nCoV.

See www.health.gov.au for up-to-date areas with sustained transmission and close contact definition.

Clinical criteria: at least one of the following

  • Fever or history of fever (≥38°C) and acute respiratory infection (sudden onset of respiratory infection with at
    least one of: shortness of breath, cough or sore throat).
  • Severe acute respiratory infection requiring admission to hospital with clinical or radiological evidence of
  • pneumonia or acute respiratory distress syndrome (i.e. even if no evidence of fever).

Medical practitioners are advised to: 

  • Be alert for patients of any age meeting the suspected case definition – noting that most returning 
    travellers will have more common viral or bacterial respiratory infections.
  • Assess patients with suspected 2019-nCoV infection using transmission based precautions in 
    addition to standard precautions
    • ​Put surgical mask on patient and ask to observe respiratory (cough) etiquette.
    • Social distancing i.e. move patient from general waiting area and use a single room, if available.
    • Staff examining patient to wear gloves, disposable gown, P2/N95 respirator mask (if available, if
      not available then wear a surgical mask) and eye protection.
    • Hand hygiene with alcohol hand rub, or if hands visibly soiled, soap and water.
    • Avoid aerosol generating procedures, if possible.
  • Contact the CDCB medical officer on 1300 232 272 (24/7) to discuss any suspected cases.
  • Consider laboratory testing
    • ONLY cases meeting the current case definition should be tested for 2019-nCoV.
    • Routine respiratory panel testing (which includes influenza) should always be requested if clinically
      indicated, as most patients with a respiratory illness will have a more common aetiology.
    • If, following discussion with the CDCB medical officer, your patient requires testing for 2019-nCoV
      ​then call your preferred laboratory to obtain details of the specimen and swab(s) required.
    • If you have access to the recommended PPE for collection of a respiratory specimen for suspected
      2019-CoV, then do so in your surgery or emergency department. The required PPE consists of a
      P2/N95 respirator, gloves, disposable gown and eye protection. If you do not have this PPE
      ​discuss alternative options with the CDCB medical officer.
    • DO NOT send a patient with suspected 2019-CoV to a laboratory collection centre.
  • Except in urgent circumstances, only transfer patients with suspected 2019-nCoV to an
    emergency department after discussion with CDCB.

See SA Health www.sahealth.sa.gov.au/InfectiousDiseaseControl , the Australian Government Department
of Health website at https://www.health.gov.au/news/novel-coronavirus-update and the World Health
Organization website at https://www.who.int/health-topics/coronavirus
 

 

Dr Louise Flood – Director, Communicable Disease Control Branch
For all enquires please contact the CDCB on 1300 232 272 (24 hours/7 days)
For public health alerts see: www.sahealth.sa.gov.au/HealthAlerts

Public – I2-A2

Download the official health alert here (PDF)
 

Novel Coronavirus Pneumonia in Wuhan, China

10 January 2020 -  Novel Coronavirus Pneumonia in Wuhan, China

Chinese health authorities have reported 59 cases of viral pneumonia, with no deaths (at 5 January 2020),
all confined to Wuhan city in Hubei Province, China. There is a common epidemiological link with the
Wuhan South China Seafood City Market (also called the South China Seafood Wholesale Market and the Hua Nan Seafood Market).
The market has been closed since January 1, 2020 for cleaning and disinfection.  

COMMUNICABLE DISEASE 
CONTROL BRANCH
- Attention all doctors - 
Date: 10/01/2020   Contact telephone number: 1300 232 272  (24 hours/7 days)

 

Novel Coronavirus Pneumonia in Wuhan, China

 

Chinese health authorities have reported 59 cases of viral pneumonia, with no deaths (at 5
January 2020), all confined to Wuhan city in Hubei Province, China. There is a common
epidemiological link with the Wuhan South China Seafood City Market (also called the South
China Seafood Wholesale Market and the Hua Nan Seafood Market).
The market has been closed since January 1, 2020 for cleaning and disinfection.  

A novel coronavirus has been identified in 15 cases as the likely causative agent. There is no
evidence at this time of ongoing human to human transmission, and no reported cases in health
care workers. Note that this new illness has not been reported from other parts of China or
elsewhere. Most recent travellers from Wuhan with respiratory symptoms have been diagnosed
with influenza, RSV or other common respiratory viruses. 

Human coronaviruses are common throughout the world and can cause mild to moderate upper-
respiratory tract illnesses such as the common cold, as well as diarrhoea. Human coronaviruses
can sometimes cause severe lower-respiratory tract illnesses, such as pneumonia or bronchitis,
as has been seen with SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East
Respiratory Syndrome). 

The Commonwealth Department of Health and Health Departments in all jurisdictions including
South Australia are maintaining a watching brief on this outbreak.

Australia has excellent public health laboratory capacity to test for and identify viral and bacterial
agents, and strong public health systems and border measures to detect and manage ill
travellers. However there are no commercially available diagnostic tests for this new infectious
agent. 

Medical practitioners are advised to:  

  • Be alert for patients of any age who have travelled to Wuhan, China, within two weeks of onset of illness AND who present with fever and respiratory symptoms. 
  • Place a surgical mask on, and isolate, these patients as soon as they are identified.
  • Call the Communicable Disease Control Branch (CDCB) medical officer on 1300 232 272
    (24/7) who can provide further information on recommended testing, personal protective
    equipment (PPE) and infection control, and further management. 

Dr Ann Koehler – A/Director, Communicable Disease Control Branch 
For public health alerts see:  www.sahealth.sa.gov.au/healthalerts
For information on notifiacation see: www.sahealth.sa.gov.au/NotifiableDiseaseReporting 
For weekly epidemiology reports see: www.sahealth.sa.gov.au/SurveillanceNotifiableConditions 

Public - 12-A1

Download the official health alert here (PDF)


 

Subcategories

CONTACT US

Beckwith Park, 30 Tanunda Road Nuriootpa SA 5355
PO Box 868 Nuriootpa SA 5355
T 08 8565 8900 F 08 8311 1723
E This email address is being protected from spambots. You need JavaScript enabled to view it.

@countrysaphn

HEALTH PROFESSIONALS

THINGS WE DO

 

While the Australian Government Department of Health has contributed to the funding of this website, the information on this website does not necessarily reflect the views of the Australian Government and is not advice that is provided, or information that is endorsed, by the Australian Government. The Australian Government is not responsible in negligence or otherwise for any injury, loss or damage however arising from the use of or reliance on the information provided on this website.

© 2018 COUNTRY SA PHN  
Country SA PHN gratefully acknowledge the financial and other support from the Australian Government Department of Health